Pictured: Ross Levine
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Thursday, March 15, 2012

Researchers have identified a set of genetic abnormalities that can enhance prognostic accuracy and aid treatment selection for people with acute myelogenous leukemia (AML).

Pictured: Nai-Kong Cheung
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, March 13, 2012

In a large-scale genome-sequencing study, researchers have discovered mutations in neuroblastoma tumors that could aid the development of diagnostic tests and therapies.

Pictured: Timothy Chan
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, February 15, 2012

Two Memorial Sloan Kettering studies provide new clues about genetic mutations that affect cell behavior and play a role in several types of cancer.

Pictured: Marc Ladanyi & Laetitia Borsu
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Wednesday, February 1, 2012

Memorial Sloan Kettering researchers have performed the first large-scale genetic analysis of several pediatric cancers, identifying mutations and potential targets for therapies to treat the cancers.

Pictured: Hans-Guido Wendel
Profile
By Jim Stallard, MA, Writer/Editor  |  Tuesday, December 20, 2011

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.

Pictured: Breast tumor treated with paclitaxel
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, December 2, 2011

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.

Center News

Stay Informed

Get the latest information about cancer care and research every month.